What are CONMED's total assets?

CONMED (CNMD) holds $2.3B in total assets, up 0.8% year over year.

How much debt does CONMED have?

CONMED carries $862.6M in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 0.85.

How much cash does CONMED have?

CONMED holds $35.0M in cash and equivalents.

Can CONMED cover its short-term obligations?

Its current ratio is 2.29 — current assets exceed current liabilities.

Where does CONMED's balance sheet data come from?

Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

CONMED CNMD Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$35.03M-1.3%	$40.82M+66.9%	$38.93M+1.2%	$33.94M+17.5%	$35.49M+4.8%
Accounts receivable, net	$228.66M+3.4%	$247.83M+4.2%	$224.94M-2.7%	$234.15M-2.1%	$221.14M-8.4%
Inventories	$366.11M+3.2%	$355.54M+2.5%	$364.36M+6.4%	$362.25M+12.4%	$354.68M+10.0%
Raw materials	$112.34M-2.6%	$109.63M-4.4%	$101.83M-5.0%	$110.14M+6.8%	$115.28M+9.5%
Work in process	$41.18M+30.2%	$33.26M+6.3%	$34.75M+10.6%	$33.28M+7.0%	$31.64M+9.9%
Finished goods	$212.59M+2.3%	$212.65M+6.0%	$227.78M+11.7%	$218.83M+16.3%	$207.76M+10.4%
Prepaid expenses and other current assets	$40.79M+47.3%	$28.67M-7.8%	$33.93M+18.0%	$27.45M-17.8%	$27.7M-27.3%
Total current assets	$670.59M+4.9%	$672.86M+5.1%	$662.16M+3.3%	$657.78M+5.4%	$639M+0.5%
Property and equipment, net	$111.96M-3.5%	$113.33M-2.1%	$112.04M-4.6%	$116.86M-0.2%	$116.06M-1.6%
Accumulated depreciation	$437.58M+8.7%	$428.87M+9.0%	$419.98M+9.0%	$411.3M+9.3%	$402.4M+9.4%
Goodwill	$806.86M+0.1%	$807.01M+0.2%	$806.92M0.0%	$806.93M+0.1%	$805.7M-0.1%
Intangible assets, net	$573.8M-5.9%	$582.05M-5.8%	$593.11M-5.2%	$601.82M-5.0%	$609.83M-4.9%
Other non-current assets	$151.73M+19.4%	$150.5M+29.3%	$148.27M+18.7%	$145.07M+37.8%	$127.09M+17.7%
Total assets	$2.31B+0.8%	$2.33B+0.8%	$2.32B+0.3%	$2.33B+1.9%	$2.3B-0.5%
Accounts payable	$105.42M+10.1%	$93.65M-8.4%	$107.09M+2.4%	$101.05M-0.2%	$95.73M-5.8%
Accrued expenses	$60.89M+5.5%	$82.14M+25.7%	$76.13M+23.9%	$67.95M+22.9%	$57.7M+15.6%
Current portion of long-term debt	$711K-0.4%	$712K-0.4%	$746K+4.0%	$714K-0.3%	$714K+3.2%
Contract liabilities	$23.41M+16.7%	$21.97M+19.2%	$21.04M+15.7%	$20.39M+8.9%	$20.06M+9.5%
Dividends payable	——	——	——	——	——
Total current liabilities	$292.72M+3.4%	$315.04M+13.3%	$314.7M+11.5%	$294.84M+10.7%	$283.15M-2.8%
Long-term debt	$860.87M-3.5%	$834.94M-7.8%	$853.75M-9.3%	$881.83M-8.7%	$892.16M-10.0%
Finance Lease Liabilities (Total)	$1.07M-37.8%	$1.23M-34.2%	$1.4M-31.0%	$1.56M-28.4%	$1.72M-22.1%
Finance lease liabilities	$1.07M-37.8%	$521K-55.0%	$1.4M-31.0%	$1.56M-28.4%	$1.72M-22.1%
Other non-current liabilities	$63.02M-16.5%	$63.85M-26.0%	$71.66M-24.3%	$79.82M-25.6%	$75.5M-30.8%
Total liabilities	$1.3B-1.7%	$1.29B-3.8%	$1.31B-5.0%	$1.33B-5.6%	$1.32B-9.2%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	100M0.0%	100M+31,849%	100M0.0%	100M0.0%	100M0.0%
Additional paid-in capital	$508.49M+4.0%	$503.2M+5.6%	$498.67M+5.9%	$494.04M+6.3%	$489.1M+6.8%
Retained earnings	$602.59M+7.6%	$588.77M+5.1%	$572.03M+7.4%	$575.36M+17.4%	$560.13M+20.2%
Accumulated other comprehensive income (loss)	-$44.69M+22.1%	-$46.3M+21.3%	-$49.23M+10.0%	-$52.98M+2.7%	-$57.39M-15.2%
Treasury stock	$49.04M+238%	$12.89M-17.5%	$13.52M-17.0%	$13.86M-26.0%	$14.51M-27.3%
Total stockholders' equity	$1.02B+4.1%	$1.03B+7.3%	$1.01B+8.1%	$1B+13.7%	$977.64M+14.4%
Total liabilities and stockholders' equity	$2.31B+0.8%	$2.33B+0.8%	$2.32B+0.3%	$2.33B+1.9%	$2.3B-0.5%
Finished goods	$212.59M+2.3%	$212.65M+6.0%	$227.78M+11.7%	$218.83M+16.3%	$207.76M+10.4%
Derivative Assets - Fair Value	$6.26M+48.8%	$4.44M-51.4%	$3.22M+248%	$1.95M-64.6%	$4.2M-39.1%
Deferred Tax Assets and Other Non-Current Assets	$151.73M+19.4%	$150.5M+29.3%	$148.27M+18.7%	$145.07M+37.8%	$127.09M+17.7%
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)	——	——	——	——	——
Intangible Assets Gross (Excluding Goodwill)	$1.01B-0.1%	$1.01B0.0%	$1.01B+0.2%	$1.01B+0.3%	$1.01B+0.3%
Deferred tax assets	——	——	——	——	——
Other intangible assets—net	$573.8M-5.9%	$582.05M-5.8%	$593.11M-5.2%	$601.82M-5.0%	$609.83M-4.9%
Other non-current assets	$151.73M+19.4%	$150.5M+29.3%	$148.27M+18.7%	$145.07M+37.8%	$127.09M+17.7%
Software and Technology Licenses, Net	$151.73M+19.4%	$150.5M+29.3%	$148.27M+18.7%	$145.07M+37.8%	$127.09M+17.7%
Accrued Manufacturing Costs	$60.89M+5.5%	$82.14M+25.7%	$76.13M+23.9%	$67.95M+22.9%	$57.7M+15.6%
Compensation and benefits	$60.89M+5.5%	$82.14M+25.7%	$76.13M+23.9%	$67.95M+22.9%	$57.7M+15.6%
Other accrued liabilities	$125.7M-2.6%	$138.54M+26.2%	$130.74M+13.1%	$125.12M+14.6%	$129M-7.3%
Current Portion of Long-Term Debt and Finance Lease Obligations	$711K-0.4%	$712K-0.4%	$746K+4.0%	$714K-0.3%	$714K+3.2%
Derivative Liabilities - Fair Value	$3.83M+8.3%	$5.94M+68.3%	$6.72M-1.1%	$10.57M+388%	$3.53M+263%
Standard Product Warranty Accrual	$1.4M+0.4%	$1.32M-8.4%	$1.33M-13.2%	$1.37M-11.6%	$1.39M-16.4%
Debt Maturity - 2024	——	——	——	——	——
Debt Maturity - 2027	——	——	——	——	——
Long-Term Debt and Finance Lease Obligations	$860.16M-3.5%	$834.23M-7.8%	$853.01M-9.3%	$881.11M-8.7%	$891.44M-10.0%
Total debt	$862.65M-3.6%	$889.43M-6.4%	$855.9M-9.3%	$884.1M-8.7%	$894.59M-10.0%
Common Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common Stock Shares Issued	31.3M0.0%	31.3M0.0%	31.3M0.0%	31.3M0.0%	31.3M0.0%
Convertible Preferred Stock Authorized Shares	500K0.0%	500K0.0%	500K0.0%	500K0.0%	500K0.0%
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$313K0.0%	$313K0.0%	$313K0.0%	$313K0.0%	$313K0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Preferred Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Fair Value Measurement Disclosure	$3.83M+8.3%	$5.94M+68.3%	$6.72M-1.1%	$10.57M+388%	$3.53M+263%
Gross Assets/Liabilities	$3.83M+8.3%	$5.94M+68.3%	$6.72M-1.1%	$10.57M+388%	$3.53M+263%
Common stock, par value (in dollars per share)	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%	$100M0.0%
Common stock, shares issued (in shares)	$31.3M0.0%	$31.3M0.0%	$31.3M0.0%	$31.3M0.0%	$31.3M0.0%
Contract with Customer, Liability	$23.41M+16.7%	$21.97M+19.2%	$21.04M+15.7%	$20.39M+8.9%	$20.06M+9.5%
Debt Instrument, Covenant, Aggregate Principal Amount Early Maturing Threshold	——	——	——	——	——
Debt Instrument, Covenant, Minimum Liquidity Amount	——	——	——	——	——
Deferred income taxes	$81.38M+16.3%	$79.53M+7.4%	$74.86M+13.7%	$69.82M+7.5%	$69.95M+9.3%
Derivative Assets Liabilities At Fair Value Net	$2.43M+262%	-$1.5M-127%	-$3.5M+40.4%	-$8.62M-358%	$671K-88.7%
Derivative, gross, assets	$6.26M+48.8%	$4.44M-51.4%	$3.22M+248%	$1.95M-64.6%	$4.2M-39.1%
Derivatives, gross, liabilities	$3.83M+8.3%	$5.94M+68.3%	$6.72M-1.1%	$10.57M+388%	$3.53M+263%
Finite-Lived Intangible Assets, Accumulated Amortization	$437.58M+8.7%	$428.87M+9.0%	$419.98M+9.0%	$411.3M+9.3%	$402.4M+9.4%
2028	——	——	——	——	——
2030	——	——	——	——	——
2031	——	——	——	——	——
Remainder of 2026	——	——	——	——	——
2027	——	——	——	——	——
2029	——	——	——	——	——
Indefinite- lived intangible impairment	$1.01B-0.1%	$1.01B0.0%	$1.01B+0.2%	$1.01B+0.3%	$1.01B+0.3%
Long-Term Debt and Lease Obligation	$860.16M-3.5%	$834.23M-7.8%	$853.01M-9.3%	$881.11M-8.7%	$891.44M-10.0%
Less: current maturities	$711K-0.4%	$712K-0.4%	$746K+4.0%	$714K-0.3%	$714K+3.2%
2028	——	——	——	——	——
2029	——	——	——	——	——
2029	——	——	——	——	——
2030	——	——	——	——	——
2027	——	——	——	——	——
Remainder of 2026	——	——	——	——	——
Preferred Stock, Par or Stated Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Preferred Stock, Shares Authorized	$500K0.0%	$500K0.0%	$500K0.0%	$500K0.0%	$500K0.0%
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—	$0—
Standard Product Warranty Accrual	$1.4M+0.4%	$1.32M-8.4%	$1.33M-13.2%	$1.37M-11.6%	$1.39M-16.4%
Treasury stock, shares (in shares)	$1.16M+213%	$328.1K-17.5%	$344.14K-17.0%	$352.9K-26.0%	$369.43K-27.3%
Remainder of Fiscal Year 2024	——	——	——	——	——
Remainder of Fiscal Year 2025	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about CONMED.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are CONMED's total assets?: CONMED (CNMD) holds $2.3B in total assets, up 0.8% year over year.
How much debt does CONMED have?: CONMED carries $862.6M in total debt against $1.0B of shareholders' equity, a debt-to-equity ratio of 0.85.
How much cash does CONMED have?: CONMED holds $35.0M in cash and equivalents.
Can CONMED cover its short-term obligations?: Its current ratio is 2.29 — current assets exceed current liabilities.
Where does CONMED's balance sheet data come from?: Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.